Skip to content

Search

Showing results for "early lung health"

Genome-wide methylation analysis identifies differentially methylated CpG loci associated with severe obesity in childhood.

This study identifies widespread DNA methylation changes in whole blood associated with childhood obesity.

The pet factor - Companion animals as a conduit for getting to know people, friendship formation and social support

Pet owners were significantly more likely to get to know people in their neighborhood than non-pet owners.

About us

CliniKids is a not-for-profit centre integrating world-class research with a clinical service for children with developmental delay and/or autism, and their families. It is the first of its kind for autism in Australia.

New focus on type 2 diabetes

Researchers at the Children’s Diabetes Centre at The Kids Research Institute Australia have begun researching type 2 diabetes to tackle the rising incidence of the disease among young people in Australia.

Covid Vaccination Statement

Re: Recommendations from the Diabetes and Endocrinology Department at Perth Children’s Hospital and the Children’s Diabetes Centre at The Kids Research Institute Australia regarding COVID-19 vaccination for children with diabetes

Looking at the Big Food Picture For T1D

Kids with diabetes should think beyond just carbs, according to The Kids Research Institute Australia senior dietitian Dr Amelia Harray.

Where's the meat? And what's it doing to my HbA1c?

Patients require on average about 50 per cent more insulin with a high protein meal than with a low protein meal. A study conducted by the Children's Diabetes Centre used an insulin clamp technique to determine insulin requirements to maintain euglycaemia across the different meals.

Systematic In Vitro Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged Leukemia

Patients whose leukemias harbor a rearrangement of the Mixed Lineage Leukemia (MLL/KMT2A) gene have a poor prognosis, especially when the disease strikes in infants. The poor clinical outcome linked to this aggressive disease and the detrimental treatment side-effects, particularly in children, warrant the urgent development of more effective and cancer-selective therapeutics.